Kinvestor
News
Markets
Earnings
Insider
Portfolio
Pricing
Get Started
KROS
Keros Therapeutics Inc
Biotechnology
+ Watchlist
View SEC Filings
Overview
Financials
Earnings
Insider
Ownership
Filings
News
Keros Therapeutics Inc (KROS) Earnings
Last reported
April 30, 2026
EPS estimate
-$1.11
EPS actual
—
Revenue est.
$510.0K
Revenue actual
—
Related:
KROS overview
·
KROS financials
·
KROS news